韦卫琴,向璇,房东海,虞晓红,陈我婵,赵九艳
WEI Weiqin,XIANG Xuan,FANG Donghai,YU Xiaohong,CHEN Wochan,ZHAO Jiuyan

• 1:贵州医科大学附属医院急诊科
• 2:贵阳市第二人民医院急诊科

摘要(Abstract)：

目的:探讨持续性血液净化(CBP)和间断性血液净化(IBP)治疗腹腔感染合并腹腔高压(IAH)患者的疗效。方法:47例腹腔感染合并IAP患者随机分为CBP组(n=21)和IBP组(n=26),2组患者在常规治疗基础上均给予连续性静脉-静脉血液滤过和血液灌流,CBP组连续治疗(48±12) h,IBP组连续治疗(8±2) h、间隔24 h再次进行,共治疗3次;收集2组患者治疗前及治疗结束后APACHEⅡ评分及序贯器官衰竭评分(SOFA评分),检测血清降钙素原(PCT)、白细胞介素6(IL-6)、C反应蛋白(CRP)、动脉血乳酸(Lac)和乳酸清除率,观察IAP变化、胃肠道功能恢复时间、ICU停留时间及28 d死亡情况。结果:2组患者治疗后PCT、IL-6、CRP、Lac、IAP、SOFA评分及APACHEⅡ评分均较治疗前降低,差异均有统计学意义(P <0. 05); 2组患者间治疗后乳酸清除率、IAP、SOFA评分及APACHEⅡ评分比较,差异有统计学意义(P <0. 05)。结论:CBP与IBP对腹部创伤和外科急腹症术后腹腔感染并IAP治疗均有效,CBP治疗对器官功能维护优于IBP治疗,但2种治疗方法对临床结局的影响无差异。
Objective: To explore the efficacy of continuous blood purification( CBP) and intermittent blood purification( IBP) in the treatment of patients with intra-abdominal infection and intra-abdominal hypertension( IAH). Methods: Forty-seven patients with intra-abdominal infection and IAP( intra-abdominal pressure) were randomly divided into CBP group( n = 21) and IBP group( n = 26). Both groups were given continuous vein-vein hemofiltration and hemoperfusion( CVVH +HP) on the basis of conventional treatment. The CBP group received continuous treatment( 48 ± 12)h; the group of IBP was treated for( 8 ± 2) h continuously and conducted the treatment again after 24-h interval for a total of 3 treatments. The score of APACHE( acute pathologic and chronic health evaluation Ⅱ) and sepsis related organ failure assessment( SOFA) were collected before and after treatment between the two groups. The serum procalcitonin( PCT),interleukin 6( IL-6),C-reactive protein( CRP),arterial blood lactic acid( Lac) and lactic acid clearance rate were measured. IAP changes,recovery time of gastrointestinal function,ICU staying,and 28 days of death status were observed. Results: The PCT,IL-6,CRP,Lac,IAP,SOFA score,and APACHEⅡscore of patients were all lower than before treatment,and the differences were statistically significant( P < 0. 05). The lactic acid clearance rate,IAP,SOFA score,and APACHEⅡscore were compared between the two groups,and the difference was statistically significant( P < 0. 05). Conclusions: CBP and IBP are effective in treating abdominal trauma and postoperative abdominal infection with IAP. CBP is better than IBP for organ function maintenance,but the two treatment methods have no difference in clinical outcome.

关键词(KeyWords)： 血液;腹腔感染;腹腔高压;腹腔间隔室综合征;间段性血液净化;炎性因子;乳酸清除率;临床结局
blood;intra-bdominal infection;intra-abdominal hypertension(IAH);abdominal compartment syndrome(ACS);intermittent blood purification;inflammatory factor;lactic acid clearance rate;clinical outcome

Abstract:

Keywords:

基金项目(Foundation): 贵州省卫生计划委员会基金资助项目(gzwjkj 2016-1-872)

作者(Author): 韦卫琴,向璇,房东海,虞晓红,陈我婵,赵九艳
WEI Weiqin,XIANG Xuan,FANG Donghai,YU Xiaohong,CHEN Wochan,ZHAO Jiuyan

DOI: 10.19367/j.cnki.2096-8388.2020.12.014

参考文献(References)：

• [1] ROGERS W K,GARCIA L. Intraabdominal hypertension,abdominal compartment syndrome,and the open abdomen[J]. Chest,2018,153(1):238-250.
• [2]KIRKPATRICK A W,COCCOLINI F,ANSALONI L,et al. Closed or open after source control laparotomy for severe complicated intra-abdominal sepsis(the COOL trial):study protocol for a randomized controlled trial[J].World J Emerg Surg,2018,22(13):26.
• [3]OLONEN M,COCCOLINI F,ANSALONI L,et al. Getting the invite list right:a discussion of sepsis severity scoring systems in severe complicated intra-abdominal sepsis and randomized trial inclusion criteria[J]. World J Emerg Surg,2018,6(13):17.
• [4]刘冬，张宏光，张连阳．腹腔高压症/腹腔间隙综合征研究进展[J]．灾害医学与救援(电子版)，2015,4(3):191-195.
• [5]KIRKPATRICK A W,ROBERTS D J,DE WAELE J,et al. Intra-abdominal hypertension and the abdominal compartment syndrome:updated consensus definitions and clinical practice guidelines from the world society of the abdominal compartment syndrome[J]. Intensive Care Med,2013,39(7):1190-206.
• [6]须欣，黄曼，王鹏飞，等．持续性血液净化治疗对腹腔内高压患者的胃肠功能障碍的影响[J]．中华急诊医学杂志，2014,23(10):1138-1142.
• [7]COCCOLINI F,ROBERTS D,ANSALONI L,et al. The open abdomen in trauma and non-trauma patients:WSES guidelines[J]. World J Emerg Surg,2018,2(13):7.
• [8]王昱，陶琨，郁水华，等．连续性血液净化治疗脓毒症合并腹腔高压的疗效观察[J]．中华危重病急救医学，2015,27(5):392-394.
• [9]SPOTO S,NOBILE E,CARNA E P R,et al. Best diagnostic accuracy of sepsis combining SIRS criteria or q SOFA score with procalcitonin and Mid-regional pro-adrenomedullin outside ICU[J]. Sci Rep,2020,10(1):16605.
• [10]DAHABA A A,ELAWADY G A,REHAK P H,et al.Procalcitonin and proinflammatory cytokine clearance during continuous venovenous haemofiltration in septic patients[J]. Anaesth Intensive Care,2002,30(3):269-274.
• [11]MEISNER M,HUTTEMANN E,LOHS T,et al. Plasma concentrations and clearance of procalcitonin during continuous veno-venous hemofiltration in septic patients[J].Shock,2001,15(3):171-175.
• [12]MEISNER M,HUTTEMANN E,LOHS T,et al. Elimination of procalcitonin and plasma concentrations during continuous veno-venous haemodiafiltration in septic patients[J]. Eur J Anaesthesiol,2000,17(11):665-671.
• [13]KADE G,LITERACKI S,RZESZOTARSKA A,et al.Removal of procalcitonin and selected cytokines during continuous veno-venous hemodialysis using high cutoff hemofilters in patients with sepsis and acute didney injury[J]. Blood Purif,2018,46(2):153-159.
• [14]康福新，王瑞兰．脓毒症早期诊断的生物标志物[J]．中国危重病急救医学，2007,19(10):633-635.
• [15]柳东之，马卫星，曾燕萍，等．连续肾脏替代疗法治疗腹腔高压第三间隙效应患者的临床研究[J]．中华全科医学，2019,17(1):44-46.
• [16]磨红，赵志权．连续性血液净化治疗难治性心力衰竭的疗效观察[J]．中国中西医结合急救杂志，2007,14(4):251-251.
• [17]KLUGE S,DEHEER G,JARCZAK D,et al. Laktatazidose-update 2018[Lactic acidosis-update 2018][J].Dtsch Med Wochenschr,2018,143(15):1082-1085.
• [18]张淇钏，方喜斌，蔡志雄，等．早期连续性血液净化治疗乳酸酸中毒的应用[J]．中华危重病急救医学，2013,25(1):45-47.
• [19]王昱，陶琨，郁水华，等．连续性血液净化治疗脓毒症合并腹腔高压的疗效观察[J]．中华危重病急救医学，2015,27(5):392-394.
• [20]DELAET I,DEEREN D,SCHOONHEYDT K,et al. Renal replacement therapy with net fluid removal lowers intra-abdominal pressure and volumetric indices in critically ill patients[J]. Ann Intensive Care,2012(Suppl 1):S20.
• [21]曹钰，柴艳芬，邓颖，等．中国脓毒症/脓毒性休克急诊治疗指南(2018)[J]．感染、炎症、修复，2019,20(1):3-22.
• [22]冉晓，李树生．内毒素吸附治疗脓毒症的研究进展[J]．中国血液净化，2019,18(2):134-136.
• [23]MONARD C,RIMMELE T,RONCO C. Extracorporeal blood purification therapies for sepsis[J]. Blood Purif,2019,47(3):1-14.
• [24]SCHWINDENHAMMER V,GIRARDOT T,CHAULIER K,et al. o Xirisuse in septic shock:experience of two french centres[J]. Blood Purif,2019,47(3):1-7.

文章评论(Comment)：